Skip to content

To study the number of children effected with respiratory allergic disorders and effect of ayurvedic compound Brihat vasavleh and Shadbindu tail nasya reduce the allergic infection in children. Also to study the various factors responsible for the respiratory allergic disorder in children.

COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF BRIHAT VASAVLEHA AND SHADBINDU TAIL NASYA IN THE MANAGEMENT OF PRANAVAHA SROTO DUSHTI W.S.R. OF RESPIRATORY ALLERGIC DISORDERS IN CHILDREN - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082008
Enrollment
60
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children whose parents are willing to give consent/assent for clinical trial. Children having cardinal features of respiratory allergy. Children aged between 06 years to 14 years of either sex. Children with a history of three or more episode within the past year.

Exclusion criteria

Exclusion criteria: Children cases of respiratory allergies that are severe and complicated. Children aged below 06 years and above 14 years of either sex. Children suffering from major systemic illness necessitating long-term treatment. Children with evidence of malignancy, genetic or congenital anomaly. Children diagnosed with Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchiectasis, Pleurisy, Nasal polyps etc. H/o hypersensitivity to any of the trial drug or their ingredient. .

Design outcomes

Primary

MeasureTime frame
to check the effectiveness and efficacy of the drug and procedure in Respiratory Allergic DisordersTimepoint: 56 days

Secondary

MeasureTime frame
To compare both the drugsTimepoint: 56 days

Countries

India

Contacts

Public ContactProf Ram Kumar

Madan Mohan Malviya Government Ayurved College Udaipur,

drbhamuramkumar@gmail.com8005857838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026